Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

Overview of attention for article published in Radiation Oncology, January 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 11,603 followers.

RT @DrewMoghanaki: SBRT & VATS are each so promising that @drdavidpalma & colleagues are testing both in the same patient #lcsm #radonc htt…

SBRT & VATS are each so promising that @drdavidpalma & colleagues are testing both in the same patient #lcsm #radonc https://t.co/2IEoc94x9H

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.